An in silico platform for the design of heterologous pathways in nonnative metabolite production

BMC Bioinformatics

Volumn 13, Issue 1, 2012, Pages

  Chatsurachai, Sunisa ^a   Furusawa, Chikara ^a,b   Shimizu, Hiroshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR GROWTH; CORYNEBACTERIUM GLUTAMICUM; FLUX BALANCE ANALYSIS; IN-SILICO; INDUSTRIAL PROCESSS; METABOLIC NETWORK; METABOLIC PATHWAYS; METABOLIC REACTIONS; METABOLITE PRODUCTION; PRODUCTION OF;

ALGORITHMS; BIOMOLECULES; COMPLEX NETWORKS; ESCHERICHIA COLI; METABOLISM; MICROORGANISMS; YEAST;

METABOLITES;

CORYNEBACTERIUM GLUTAMICUM; ESCHERICHIA COLI; SACCHAROMYCES CEREVISIAE;

ALGORITHM; ARTICLE; COMPUTER SIMULATION; CORYNEBACTERIUM GLUTAMICUM; ESCHERICHIA COLI; METABOLISM; SACCHAROMYCES CEREVISIAE;

ALGORITHMS; COMPUTER SIMULATION; CORYNEBACTERIUM GLUTAMICUM; ESCHERICHIA COLI; METABOLIC NETWORKS AND PATHWAYS; SACCHAROMYCES CEREVISIAE;

EID: 84860819691     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-13-93     Document Type: Article

References (67)

1. Dugar D, Stephanopoulos G. Relative potential of biosynthetic pathways for biofuels and bio-based products. Nat Biotechnol 2011, 29:1074-1078. 10.1038/nbt.2055, 22158355.
2. Lee SK, Chou H, Ham TS, Lee TS, Keasling JD. Metabolic engineering of microorganisms for biofuels production: from bugs to synthetic biology to fuels. Curr Opin Biotechnol 2008, 19:556-563. 10.1016/j.copbio.2008.10.014, 18996194.
3. Schneider J, Wendisch VF. Biotechnological production of polyamines by bacteria: recent achievements and future perspectives. Appl Microbiol Biotechnol 2011, 91:17-30. 10.1007/s00253-011-3252-0, 21552989.
4. Papini M, Salazar M, Nielsen J. Systems biology of industrial microorganisms. Adv Biochem Eng Biotechnol 2010, 120:51-99.
5. Lee JW, Kim HU, Choi S, Yi J, Lee SY. Microbial production of building block chemicals and polymers. Curr Opin Biotechnol 2011, 22:758-767. 10.1016/j.copbio.2011.02.011, 21420291.
6. McEwen JT, Atsumi S. Alternative biofuel production in non-natural hosts. Curr Opin Biotechnol 2012, 23:1-7. 10.1016/j.copbio.2011.12.020, 22244690.
7. Wang B-W, Shi A-Q, Tu R, Zhang X-L, Wang Q-H, Bai F-W. Branched-Chain Higher Alcohols. Adv Biochem Eng Biotechnol 2012, 128:101-18.
8. Liu H, Xu Y, Zheng Z, Liu D. 1,3-Propanediol and its copolymers: research, development and industrialization. Biotechnol J 2010, 5:1137-48. 10.1002/biot.201000140, 21058316.
9. Ohya N, Koyama PT. Biopolymers Online 2005, 73-81. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA.
10. Smith KM, Cho K-M, Liao JC. Engineering Corynebacterium glutamicum for isobutanol production. Appl Microbiol Biotechnol 2010, 87:1045-55. 10.1007/s00253-010-2522-6, 2886118, 20376637.
11. Keasling JD. Manufacturing molecules through metabolic engineering. Science (New York, N.Y.) 2010, (330):1355-8.
12. Li H, Zhang G, Deng A, Chen N, Wen T. De novo engineering and metabolic flux analysis of inosine biosynthesis in Bacillus subtilis. Biotechnol Lett 2011, 33:1575-80. 10.1007/s10529-011-0597-5, 21424839.
13. Wang C, Yoon S-H, Jang H-J, Chung Y-R, Kim J-Y, Choi E-S, Kim S-W. Metabolic engineering of Escherichia coli for α-farnesene production. Metab Eng 2011, 13:648-655. 10.1016/j.ymben.2011.08.001, 21907299.
14. Gulevich AY, Skorokhodova AY, Sukhozhenko AV, Shakulov RS, Debabov VG. Metabolic engineering of Escherichia coli for 1-butanol biosynthesis through the inverted aerobic fatty acid β-oxidation pathway. Biotechnol Lett 2011,
15. Li S, Wen J, Jia X. Engineering Bacillus subtilis for isobutanol production by heterologous Ehrlich pathway construction and the biosynthetic 2-ketoisovalerate precursor pathway overexpression. Appl Microbiol Biotechnol 2011, 91:577-89. 10.1007/s00253-011-3280-9, 21533914.
16. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y. KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36:D480-4. 2238879, 18077471.
17. Chang A, Scheer M, Grote A, Schomburg I, Schomburg D. BRENDA, AMENDA and FRENDA the enzyme information system: new content and tools in 2009. Nucleic Acids Res 2009, 37:D588-92. 10.1093/nar/gkn820, 2686525, 18984617.
18. Bairoch A. The ENZYME database in 2000. Nucleic Acids Res 2000, 28:304-5. 10.1093/nar/28.1.304, 102465, 10592255.
19. McShan DC, Rao S, Shah I. PathMiner: predicting metabolic pathways by heuristic search. Bioinformatics (Oxford, England) 2003, 19:1692-8.
20. Li C, Henry C, Jankowski M, Ionita J, Hatzimanikatis V, Broadbelt L. Computational discovery of biochemical routes to specialty chemicals. Chem Eng Sci 2004, 59:5051-5060.
21. Handorf T, Ebenhöh O, Heinrich R. Expanding metabolic networks: scopes of compounds, robustness, and evolution. J Mol Evol 2005, 61:498-512. 10.1007/s00239-005-0027-1, 16155745.
22. Rodrigo G, Carrera J, Prather KJ, Jaramillo A. DESHARKY: automatic design of metabolic pathways for optimal cell growth. Bioinformatics (Oxford, England) 2008, 24:2554-6.
23. Dogrusoz U, Cetintas A, Demir E, Babur O. Algorithms for effective querying of compound graph-based pathway databases. BMC Bioinformatics 2009, 10:376. 10.1186/1471-2105-10-376, 2784781, 19917102.
24. Henry CS, Broadbelt LJ, Hatzimanikatis V. Discovery and analysis of novel metabolic pathways for the biosynthesis of industrial chemicals: 3-hydroxypropanoate. Biotechnol Bioeng 2010, 106:462-73.
25. Cho A, Yun H, Park JH, Lee SY, Park S. Prediction of novel synthetic pathways for the production of desired chemicals. BMC Syst Biol 2010, 4:35. 10.1186/1752-0509-4-35, 2873314, 20346180.
26. Varma A, Palsson BO. Path finding methods accounting for stoichiometry in metabolic networks. Genome Biol 2011, 12:R49. 10.1186/gb-2011-12-5-r49, 3219972, 21619601.
27. Yousofshahi M, Lee K, Hassoun S. Probabilistic pathway construction. Metab Eng 2011, 13:435-44. 10.1016/j.ymben.2011.01.006, 21292021.
28. Flórez LA, Gunka K, Polanía R, Tholen S, Stülke J. SPABBATS: A pathway-discovery method based on Boolean satisfiability that facilitates the characterization of suppressor mutants. BMC Syst Biol 2011, 5:5. 10.1186/1752-0509-5-5, 3024933, 21219666.
29. Moriya Y, Shigemizu D, Hattori M, Tokimatsu T, Kotera M, Goto S, Kanehisa M. PathPred: an enzyme-catalyzed metabolic pathway prediction server. Nucleic Acids Res 2010, 38:W138-43. 10.1093/nar/gkq318, 2896155, 20435670.
30. Pharkya P, Burgard AP, Maranas CD. OptStrain: A computational framework for redesign of microbial production systems. Genome Res 2004, 14:2367-2376. 10.1101/gr.2872004, 525696, 15520298.
31. Burgard AP, Pharkya P, Maranas CD. Optknock: a bilevel programming framework for identifying gene knockout strategies for microbial strain optimization. Biotechnol Bioeng 2003, 84:647-57. 10.1002/bit.10803, 14595777.
32. Shen CR, Lan EI, Dekishima Y, Baez A, Cho KM, Liao JC. Driving forces enable high-titer anaerobic 1-butanol synthesis in Escherichia coli. Appl Environ Microbiol 2011, 77:2905-15. 10.1128/AEM.03034-10, 3126405, 21398484.
33. Clomburg JM, Gonzalez R. Metabolic engineering of Escherichia coli for the production of 1,2-propanediol from glycerol. Biotechnol Bioeng 2011, 108:867-79. 10.1002/bit.22993, 21404260.
34. Juminaga D, Baidoo EEK, Redding-Johanson AM, Batth TS, Burd H, Mukhopadhyay A, Petzold CJ, Keasling JD. Modular engineering of L-tyrosine production in Escherichia coli. Appl Environ Microbiol 2012, 78:89-98. 10.1128/AEM.06017-11, 3255607, 22020510.
35. Becker J, Wittmann C. Bio-based production of chemicals, materials and fuels -Corynebacterium glutamicum as versatile cell factory. Curr Opin Biotechnol 2011, 23:1-10.
36. Hong K-K, Nielsen J. Metabolic engineering of Saccharomyces cerevisiae: a key cell factory platform for future biorefineries. Cell Mol Life Sci 2012, 69:1-20. CMLS, 10.1007/s00018-011-0833-0, 22009453.
37. Christina SD. The Metabolic Pathway Engineering Handbook: Fundamentals 2010, USA: CRC Press, Taylor& Francis Group, LLC, 1, Section V.
38. Zhang Y, Zhu Y, Zhu Y, Li Y. The importance of engineering physiological functionality into microbes. Trends Biotechnol 2009, 27:664-72. 10.1016/j.tibtech.2009.08.006, 19793618.
39. Mo ML, Palsson BO, Herrgård MJ. Connecting extracellular metabolomic measurements to intracellular flux states in yeast. BMC Syst Biol 2009, 3:37. 10.1186/1752-0509-3-37, 2679711, 19321003.
40. Reed JL, Vo TD, Schilling CH, Palsson BO. An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol 2003, 4:R54. 10.1186/gb-2003-4-9-r54, 193654, 12952533.
41. Shinfuku Y, Sorpitiporn N, Sono M, Furusawa C, Hirasawa T, Shimizu H. Development and experimental verification of a genome-scale metabolic model for Corynebacterium glutamicum. Microb Cell Fact 2009, 8:43. 10.1186/1475-2859-8-43, 2728707, 19646286.
42. Enzyme Nomenclature. [http://www.chem.qmul.ac.uk/iubmb/enzyme/].
43. Orth JD, Thiele I, Palsson B. What is flux balance analysis?. Nat Biotechnol 2010, 28:245-8. 10.1038/nbt.1614, 3108565, 20212490.
44. Kauffman KJ, Prakash P, Edwards JS. Advances in flux balance analysis. Curr Opin Biotechnol 2003, 14:491-6. 10.1016/j.copbio.2003.08.001, 14580578.
45. Schuetz R, Kuepfer L, Sauer U. Systematic evaluation of objective functions for predicting intracellular fluxes in Escherichia coli. Mol Syst Biol 2007, 3:119. 1949037, 17625511.
46. GLPK GNU Linear Programming Kit [http://www.gnu.org/software/glpk/], GLPK.
47. Zhao Y, Yang J, Qin B, Li Y, Sun Y, Su S, Xian M. Biosynthesis of isoprene in Escherichia coli via methylerythritol phosphate (MEP) pathway. Appl Microbiol Biotechnol 2011, 90:1915-22. 10.1007/s00253-011-3199-1, 21468716.
48. Mahishi LH, Tripathi G, Rawal SK. Poly(3-hydroxybutyrate) (PHB) synthesis by recombinant Escherichia coli harbouring Streptomyces aureofaciens PHB biosynthesis genes: effect of various carbon and nitrogen sources. Microbiol Res 2003, 158:19-27. 10.1078/0944-5013-00161, 12608576.
49. Kind S, Jeong WK, Schröder H, Wittmann C. Systems-wide metabolic pathway engineering in Corynebacterium glutamicum for bio-based production of diaminopentane. Metab Eng 2010, 12:341-51. 10.1016/j.ymben.2010.03.005, 20381632.
50. Lindahl A-L, Olsson ME, Mercke P, Tollbom O, Schelin J, Brodelius M, Brodelius PE. Production of the artemisinin precursor amorpha-4,11-diene by engineered Saccharomyces cerevisiae. Biotechnol Lett 2006, 28:571-80. 10.1007/s10529-006-0015-6, 16614895.
51. Wallaart TE, Bouwmeester HJ, Hille J, Poppinga L, Maijers NC. Amorpha-4,11-diene synthase: cloning and functional expression of a key enzyme in the biosynthetic pathway of the novel antimalarial drug artemisinin. Planta 2001, 212:460-5. 10.1007/s004250000428, 11289612.
52. Nakamura CE, Whited GM. Metabolic engineering for the microbial production of 1,3-propanediol. Curr Opin Biotechnol 2003, 14:454-9. 10.1016/j.copbio.2003.08.005, 14580573.
53. Cameron DC, Altaras NE, Hoffman ML, Shaw AJ. Metabolic engineering of propanediol pathways. Biotechnol Prog 1998, 14:116-25. 10.1021/bp9701325, 9496676.
54. Inui M, Kawaguchi H, Murakami S, Vertès AA, Yukawa H. Metabolic engineering of Corynebacterium glutamicum for fuel ethanol production under oxygen-deprivation conditions. J Mol Microbiol Biotechnol 2004, 8:243-54. 10.1159/000086705, 16179801.
55. Nielsen DR, Yoon S-H, Yuan CJ, Prather KLJ. Metabolic engineering of acetoin and meso-2, 3-butanediol biosynthesis in E. coli. Biotechnol J 2010, 5:274-84. 10.1002/biot.200900279, 20213636.
56. Altaras NE, Cameron DC. Metabolic engineering of a 1,2-propanediol pathway in Escherichia coli. Appl Environ Microbiol 1999, 65:1180-5. 91161, 10049880.
57. Lee W, Dasilva NA. Application of sequential integration for metabolic engineering of 1,2-propanediol production in yeast. Metab Eng 2006, 8:58-65. 10.1016/j.ymben.2005.09.001, 16242982.
58. Niu W, Draths KM, Frost JW. Benzene-free synthesis of adipic acid. Biotechnol Prog 2002, 18:201-11. 10.1021/bp010179x, 11934286.
59. Edwards JS, Palsson BO. The Escherichia coli MG1655 in silico metabolic genotype: its definition, characteristics, and capabilities. Proc Natl Acad Sci U S A 2000, 97:5528-33. 10.1073/pnas.97.10.5528, 25862, 10805808.
60. Varma A, Palsson BO. Stoichiometric flux balance models quantitatively predict growth and metabolic by-product secretion in wild-type Escherichia coli W3110. Appl Environ Microbiol 1994, 60:3724-31. 201879, 7986045.
61. Feist AM, Palsson BO. The biomass objective function. Curr Opin Microbiol 2010, 13:344-9. 10.1016/j.mib.2010.03.003, 2912156, 20430689.
62. Edwards JS, Ibarra RU, Palsson BO. In silico predictions of Escherichia coli metabolic capabilities are consistent with experimental data. Nat Biotechnol 2001, 19:125-30. 10.1038/84379, 11175725.
63. Fong SS, Marciniak JY, Palsson B. Description and interpretation of adaptive evolution of Escherichia coli K-12 MG1655 by using a genome-scale in silico metabolic model. J Bacteriol 2003, 185:6400-8. 10.1128/JB.185.21.6400-6408.2003, 219384, 14563875.
64. Edwards JS, Palsson BO. Metabolic flux balance analysis and the in silico analysis of Escherichia coli K-12 gene deletions. BMC Bioinformatics 2000, 1:1. 10.1186/1471-2105-1-1, 29061, 11001586.
65. Soyer OS, Pfeiffer T. Evolution under fluctuating environments explains observed robustness in metabolic networks. PLoS Comput Biol 2010, 6.
66. Cornelius SP, Lee JS, Motter AE. Dispensability of Escherichia coli's latent pathways. Proc Natl Acad Sci U S A 2011, 108:3124-9. 10.1073/pnas.1009772108, 3044393, 21300895.
67. Gerdes SY, Scholle MD, Campbell JW, Balázsi G, Ravasz E, Daugherty MD, Somera AL, Kyrpides NC, Anderson I, Gelfand MS, Bhattacharya A, Kapatral V, D'Souza M, Baev MV, Grechkin Y, Mseeh F, Fonstein MY, Overbeek R, Barabási A-L, Oltvai ZN, Osterman AL. Experimental determination and system level analysis of essential genes in Escherichia coli MG1655. J Bacteriol 2003, 185:5673-84. 10.1128/JB.185.19.5673-5684.2003, 193955, 13129938.